Clariant, CH0012142631

Clariant consensus stays neutral, analysts split on the shares

Published on 06/26/2026 at 12:32 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWS

Clariant sits with a neutral consensus from 16 analysts, with mixed Buy, Hold and Sell recommendations and a wide range of price targets for the Swiss specialty chemicals group.

Clariant, CH0012142631, Illustration mit AI erstellt.
Clariant, CH0012142631, Illustration mit AI erstellt.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-26, 12:32.

Clariant (CH0012142631) remains under close watch from the Swiss market. Consensus data compiled for the SIX-listed specialty chemicals group show a neutral recommendation profile from 16 analysts, with a wide spread of price targets for the shares. Investing.com consensus overview for Clariant

What the consensus shows today

The latest consensus snapshot lists 4 Buy recommendations, 10 Hold ratings and 2 Sell calls on Clariant, underscoring a cautious stance across the research community. The average 12?month price target stands at 8.57 Swiss francs, with estimates ranging from 6 to 11 francs. Analyst distribution and price targets

The implied upside from the average target is around 15.5 percent versus the current reference price used in the consensus, indicating moderate potential rather than a marked rerating story. For comparison in the chemicals space, large European peers such as BASF and Covestro often show wider Buy clusters when sentiment turns clearly constructive, while Clariant’s profile remains more balanced.

How investors can read the split views

The neutral stance suggests that most houses see Clariant as fairly valued on current earnings and cash flow expectations, with limited conviction for either a strong re?rating or a pronounced de?rating. In practice, this mix of 4 Buy, 10 Hold and 2 Sell ratings points to a stock where stock?specific catalysts and upcoming results will be decisive for the next move rather than broad sector flows. Consensus rating breakdown

Clariant competes globally with specialty chemicals names such as Croda International in the UK and Germany’s Evonik Industries, which each carry their own analyst consensus profiles driven by exposure to personal care, additives and industrial specialties. For retail investors, the distribution of ratings and targets across this peer group provides a useful cross?check on how research houses rank Clariant’s margin resilience and growth prospects within the sector.

Go deeper

All news and analysis on the Clariant shares

Further details on Clariant’s results, guidance and market reaction, plus historical price data and earlier research notes, are available in the dedicated topic section.

The business behind the stock

Clariant’s core business spans specialty chemicals for industrial and consumer applications, including formulations for personal care, coatings and additives, and industrial solutions. A representative product line is its high?performance pigments and additives used in plastics and coatings, designed to improve durability, color stability and environmental performance in sectors from automotive to packaging.

Where the shares trade today

The Clariant shares (CH0012142631) trade on the SIX Swiss Exchange in Zurich; a recent reference quote used in consensus calculations puts the stock at around 7.42 Swiss francs as of 2026-06-26, 10:00.

Key data on the Clariant shares

  • Company: Clariant AG
  • ISIN: CH0012142631
  • WKN: 919543
  • Ticker: CLN
  • Trading venue: SIX Swiss Exchange (Zurich)
  • Price (as of 2026-06-26, 10:00): 7.42 CHF
  • Market cap: 2.5 billion CHF (as of 2026-06-26)
  • Sector / industry: Specialty Chemicals
  • Index membership: SPI (Swiss Performance Index)
  • Next earnings date: 2026-07-24

More on the Clariant shares in social media

This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. All data and assessments are based on sources believed to be reliable at the time of publication but may change without notice. Retail investors should conduct their own research or consult a licensed financial advisor before making investment decisions.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0012142631 | CLARIANT | boerse | 69632116 | bgmi